- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 28-07-2026: Press Release
28-07-2026 | 10:41 pm
28-07-2026 | 10:41 pm
Glenmark USA launched Sugammadex Injection, bioequivalent to BRIDION®, targeting a significant annual market worth approximately $1.6 billion. This strengthens its US injectables portfolio and hospital segment presence.
No comments yet. Be the first to comment!